PATOU GARY
SEC insider (Form 3/4/5 filer). CIK 0001283535. Director at Xenon Pharmaceuticals Inc. (XENE). 12 reported Form 4/5 transactions since Sep 2024; latest on Jun 5, 2026. Located in BURNABY.
Companies PATOU GARY has filed insider reports for
- Xenon Pharmaceuticals Inc. (XENE): Director
PATOU GARY
CIK: 0001283535
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
Xenon Pharmaceuticals Inc.
Discretionary Trading P&L
Holdings
Transaction History (12 total)
- Jun 5, 2026XENE
Xenon Pharmaceuticals Inc.
SaleDirect1.3K shares at avg. $53.14$70K - Jun 3, 2026XENE
Xenon Pharmaceuticals Inc.
AwardDirectShare Option (Right to Buy)
10.5K shares- - Jun 3, 2026XENE
Xenon Pharmaceuticals Inc.
AwardDirectRestricted Share Units
1.6K shares- - Jun 1, 2026XENE
Xenon Pharmaceuticals Inc.
ExerciseDirect2.6K shares- - Jun 5, 2025XENE
Xenon Pharmaceuticals Inc.
AwardDirectShare Option (Right to Buy)
17K shares- - Jun 5, 2025XENE
Xenon Pharmaceuticals Inc.
AwardDirectRestricted Share Units
2.6K shares- - Nov 22, 2024XENE
Xenon Pharmaceuticals Inc.
Tax PaymentDirect1K shares at avg. $39.80$42K - Nov 22, 2024XENE
Xenon Pharmaceuticals Inc.
SaleDirect2K shares at avg. $41.05$84K - Nov 22, 2024XENE
Xenon Pharmaceuticals Inc.
Tax PaymentDirect649 shares at avg. $39.80$26K - Nov 22, 2024XENE
Xenon Pharmaceuticals Inc.
SaleDirect2.9K shares at avg. $41.11$117K
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Jun 5, 2026 | XENE Xenon Pharmaceuticals Inc. | Sale | 1,322 | $53.14 | $70,251 | Direct |
| Jun 3, 2026 | XENE Xenon Pharmaceuticals Inc. | Award Share Option (Right to Buy) | 10,507 | - | - | Direct |
| Jun 3, 2026 | XENE Xenon Pharmaceuticals Inc. | Award Restricted Share Units | 1,593 | - | - | Direct |
| Jun 1, 2026 | XENE Xenon Pharmaceuticals Inc. | Exercise | 2,645 | - | $0 | Direct |
| Jun 5, 2025 | XENE Xenon Pharmaceuticals Inc. | Award Share Option (Right to Buy) | 17,012 | - | - | Direct |
| Jun 5, 2025 | XENE Xenon Pharmaceuticals Inc. | Award Restricted Share Units | 2,645 | - | - | Direct |
| Nov 22, 2024 | XENE Xenon Pharmaceuticals Inc. | Tax Payment | 1,046 | $39.80 | $41,631 | Direct |
| Nov 22, 2024 | XENE Xenon Pharmaceuticals Inc. | Sale | 2,040 | $41.05 | $83,742 | Direct |
| Nov 22, 2024 | XENE Xenon Pharmaceuticals Inc. | Tax Payment | 649 | $39.80 | $25,830 | Direct |
| Nov 22, 2024 | XENE Xenon Pharmaceuticals Inc. | Sale | 2,851 | $41.11 | $117,205 | Direct |
1-10 of 12 transactions